Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis. (Q50718386)

18 March 2018

title

Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis. (English)

1 reference

18 March 2018

author name string

Amjad Horani

1

1 reference

18 March 2018

Nidal Muhanna

2

1 reference

18 March 2018

Orit Pappo

3

1 reference

18 March 2018

Alaa Melhem

4

1 reference

18 March 2018

Carlos E Alvarez

5

1 reference

18 March 2018

Sarit Doron

6

1 reference

18 March 2018

Wehbi Wehbi

7

1 reference

18 March 2018

Karussis Dimitrios

8

1 reference

18 March 2018

Scott L Friedman

9

1 reference

18 March 2018

Rifaat Safadi

10

1 reference

18 March 2018

publication date

12 October 2006

1 reference

18 March 2018

American Journal of Physiology - Gastrointestinal and Liver Physiology

published in

1 reference

18 March 2018

volume

292

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

G628-38

1 reference

18 March 2018

Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Copolymer 1 inhibits manifestations of graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Immunomodulation by the copolymer glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Glatiramer acetate (Copaxone®) therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Liver fibrosis -- from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Roles of TGF-beta in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Metallothionein gene therapy for chemical-induced liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Regulation of immunity by self-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

IL-10 receptor and coreceptor expression in quiescent and activated hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

The role of regulatory T lymphocytes in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Degradation of cytochrome P450 2E1: Selective loss after labilization of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Glatiramer Acetate (Copolymer-1, Copaxone) Promotes Th2 Cell Development and Increased IL-10 Production Through Modulation of Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Angiostatin inhibits experimental liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Glatiramer acetate for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00137.2006

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00137.2006

1 reference

18 March 2018

1 reference

18 March 2018